Alzamend Neuro Inc’s recent filing unveils that its Director AULT MILTON C III unloaded Company’s shares for reported $6138.0 on May 12 ’25. In the deal valued at $5.06 per share,1,213 shares were sold. As a result of this transaction, AULT MILTON C III now holds 8,260 shares worth roughly $26184.2.
Then, AULT MILTON C III sold 11 shares, generating $58 in total proceeds. Upon selling the shares at $5.28, the Director now owns 1,843 shares.
Before that, Hyperscale Data, Inc. bought 516,090 shares. Alzamend Neuro Inc shares valued at $278,689 were divested by the 10% Owner at a price of $0.54 per share.
Ascendiant Capital Markets initiated its Alzamend Neuro Inc [ALZN] rating to a Buy in a research note published on October 01, 2021; the price target was $8.
Price Performance Review of ALZN
On Tuesday, Alzamend Neuro Inc [NASDAQ:ALZN] saw its stock jump 0.32% to $3.17. Over the last five days, the stock has gained 7.46%. Alzamend Neuro Inc shares have fallen nearly -91.75% since the year began. Nevertheless, the stocks have fallen -69.64% over the past one year. While a 52-week high of $135.54 was reached on 01/07/25, a 52-week low of $2.75 was recorded on 06/26/25.
Levels Of Support And Resistance For ALZN Stock
The 24-hour chart illustrates a support level at 3.08, which if violated will result in even more drops to 2.99. On the upside, there is a resistance level at 3.28. A further resistance level may holdings at 3.39.
How much short interest is there in Alzamend Neuro Inc?
A steep rise in short interest was recorded in Alzamend Neuro Inc stocks on 2025-06-13, dropping by 9139.0 shares to a total of 0.14 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.15 million shares. There was a decline of -6.71%, which implies that there is a negative sentiment for the stock.
